Clever Leaves claims first EU-GMP cannabis certification in Latin America
Clever Leaves, an international cannabis company with its main operations in Colombia, said Thursday it obtained EU-Good Manufacturing Practice certification “to produce Active Pharmaceutical Ingredients (API), semi-finished and finished cannabis products for medical purposes” in its Colombian facilities.
Auxly Cannabis latest Canadian firm to reel in international footprint
Toronto-based Auxly Cannabis is the latest Canadian cannabis company to take a critical look at its international footprint.
Not all WHO cannabis recommendations would loosen international control, UN drug agency says
An analysis by a United Nations monitoring body concludes that most of the World Health Organization’s (WHO) cannabis scheduling recommendations would either have little impact on international drug controls or actually tighten requirements.
Canadian exports of medical cannabis oil jumped fivefold in 2019
Canadian-produced medical cannabis oil reached more international shores than ever last year as businesses look to leverage their first-mover advantage in new overseas markets.
Canada exported record amount of dried cannabis in 2019, but mostly to one market
Canadian businesses exported more dried medical cannabis than ever last year, but that growth is expected to be challenged when the country’s main export destination – Germany – initiates local production later this year.